SupplySide Global 2025 live: Givaudan showcases science-backed actives for cognition and gut health

CHECK OUT THE FULL ARTICLE IN NUTRITION INSIGHT

30-October-2025 | William Nichols

At SupplySide Global in Las Vegas, Nevada, US (Oct 29–30), Givaudan is showcasing its science-backed innovations for cognitive performance, stress management, and gut health. According to the company, Cereboost, Zensera, and Arrabina-P are natural actives that can enhance performance and well-being without compromising taste.

Moreover, Givaudan is offering interactive demos and new research connecting these natural compounds to measurable benefits. Cereboost improves focus and reaction time, as shown in a recent Michigan State University and PitFit study with elite drivers. Zensera supports calm and focus under stress, while Arrabina-P delivers gentle, low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) prebiotic benefits for digestive wellness.

Live on the trade show floor, Nutrition Insight sits down with Anne-Lise Auger, the global product manager for mind and energy at Givaudan, its category technical leader, Romain Le Cozannet, and Brian Appell, Givaudan’s marketing manager for health solutions, about how these innovations embody the company’s mission to unite science, sensory experience, and holistic performance in next-generation wellness solutions

How does Arrabina-P’s multi-fiber formulation help mitigate digestive discomfort while delivering microbiome benefits?
Le Cozannet: Arrabina-P’s complex of fibers includes arabinoxylan, xylooligosaccharides, beta-glucans, and lignins — all of which are naturally found in wheat straw. Specifically, arabinoxylan, which makes up the majority of the fiber in Arrabin-P, is a highly branched fiber. This complex structure means that Arrabina-P ferments much more slowly and farther down the GI tract, which mitigates the issues from other simpler prebiotic fibers, like inulin, such as gas, bloating, and GI discomfort. The tolerance study shows that taking 15 or more grams of Arrabina-P had no reported adverse events.